Harvard Bioscience Cash on Hand 2010-2025 | HBIO

Harvard Bioscience cash on hand from 2010 to 2025. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Harvard Bioscience Annual Cash on Hand
(Millions of US $)
2024 $4
2023 $4
2022 $5
2021 $8
2020 $8
2019 $8
2018 $8
2017 $5
2016 $6
2015 $7
2014 $14
2013 $26
2012 $21
2011 $18
2010 $20
2009 $17
Harvard Bioscience Quarterly Cash on Hand
(Millions of US $)
2025-03-31 $6
2024-12-31 $4
2024-09-30 $5
2024-06-30 $4
2024-03-31 $4
2023-12-31 $4
2023-09-30 $5
2023-06-30 $4
2023-03-31 $4
2022-12-31 $5
2022-09-30 $5
2022-06-30 $4
2022-03-31 $5
2021-12-31 $8
2021-09-30 $6
2021-06-30 $6
2021-03-31 $6
2020-12-31 $8
2020-09-30 $3
2020-06-30 $3
2020-03-31 $6
2019-12-31 $8
2019-09-30 $7
2019-06-30 $5
2019-03-31 $5
2018-12-31 $8
2018-09-30 $7
2018-06-30 $6
2018-03-31 $6
2017-12-31 $5
2017-09-30 $6
2017-06-30 $5
2017-03-31 $5
2016-12-31 $6
2016-09-30 $5
2016-06-30 $4
2016-03-31 $4
2015-12-31 $7
2015-09-30 $6
2015-06-30 $7
2015-03-31 $8
2014-12-31 $14
2014-09-30 $27
2014-06-30 $26
2014-03-31 $26
2013-12-31 $26
2013-09-30 $37
2013-06-30 $34
2013-03-31 $24
2012-12-31 $21
2012-09-30 $20
2012-06-30 $19
2012-03-31 $17
2011-12-31 $18
2011-09-30 $16
2011-06-30 $22
2011-03-31 $20
2010-12-31 $20
2010-09-30 $17
2010-06-30 $16
2010-03-31 $17
2009-12-31 $17
2009-09-30 $15
2009-06-30 $17
2009-03-31 $16
Sector Industry Market Cap Revenue
Computer and Technology Scientific Instruments Manufacturing $0.023B $0.094B
HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories.
Stock Name Country Market Cap PE Ratio
Bruker (BRKR) United States $6.392B 17.95
Kewaunee Scientific (KEQU) United States $0.156B 10.19